Posted inBiotechnology
Posted inBiotechnology
‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics
After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts…


















